India has put a temporary hold on all major exports of the AstraZeneca coronavirus vaccine made by Serum Institute of India (SII), the world’s biggest vaccine-maker, to meet domestic demand as infections rise, multiple sources confirmed.
A person close to the development said that in the light of rising demand for Covid-19 vaccines, the health ministry has conveyed to SII that it should prioritise deliveries to the government of India over export commitments. The entire production of 60 million doses in April will be supplied to the government.
India is, however, not officially banning Covid-19 vaccine exports. “This is a temporary move until the supply situation stabilises in the country,” said the person.
TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST RS 249 A MONTH.
Subscribe To Insights
Key stories on business-standard.com are available to premium subscribers only.Already a BS Premium subscriber? Log in NOW
What you get on Business Standard Premium?
- Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
- Pick your 5 favourite companies, get a daily email with all news updates on them.
- Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
- Preferential invites to Business Standard events.
- Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.